Immediate Impact
59 standout
Citing Papers
New advances in type 1 diabetes
2024 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Works of A.B. Feldman being referenced
Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady‐state conditions in type 1 diabetes
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| A.B. Feldman | 29 | 201 | 307 | 83 | 7 | 455 | ||
| Masoud Shirmohammadi | 17 | 151 | 263 | 192 | 8 | 469 | ||
| Saadia Aslam | 79 | 81 | 308 | 102 | 11 | 480 | ||
| Donna Moore | 96 | 126 | 202 | 41 | 10 | 508 | ||
| M. Hoffman | 5 | 283 | 294 | 367 | 5 | 502 | ||
| G. Dahlquist | 17 | 149 | 263 | 208 | 9 | 388 | ||
| Richard Mauseth | 16 | 211 | 239 | 277 | 13 | 435 | ||
| Breanne Harris | 14 | 218 | 321 | 195 | 9 | 400 | ||
| Dorothee Newbern | 12 | 67 | 85 | 48 | 11 | 462 | ||
| J. Huyet | 44 | 89 | 267 | 136 | 9 | 393 | ||
| Chris Press | 28 | 58 | 245 | 63 | 7 | 386 |
All Works
Login with ORCID to disown or claim papers
Loading papers...